CD44 and breast carcinoma: It significantly blocks the expansion CSCs generated by breast cancer MCF7 cell line, as determined by reduced expression of CD44 and ALDH1, under anchorage-independent growth conditions and the mammosphere assay (Fiorillo et al., 2016a).